Liu, Xiaoyang
Palaniyandi, Senthilkumar
Zhu, Iowis
Tang, Jin
Li, Weizhong
Wu, Xiaoling
Ochsner, Susan Park
Pauza, C. David
Cohen, Jeffrey I.
Zhu, Xiaoping http://orcid.org/0000-0002-1672-9504
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI130712, AI102680)
Article History
Received: 2 July 2018
Accepted: 5 June 2019
First Online: 9 July 2019
Competing interests
: X.Z. and X.L. declare that they have filed a provisional patent application together with the University of Maryland (LS-2018-054) for the application of blocking FcRn function as a means to therapy or to enhance vaccine design. The other authors declare no competing interests.